Diabetes forecast to hit one in 10 adults by 2030

Key points
- One in 10 adults will have diabetes by 2030, posing a huge challenge to healthcare systems around the world, according to a report on Monday.
- The number of people living with the disease is expected to soar to 552 million by 2030 - equating to three new cases every 10 seconds - up from 366 million in 2011, unless urgent action is taken, the International Diabetes Federation said.
- The vast majority of diabetics have Type 2 disease - the kind linked to poor diet, obesity and lack of exercise - and the problem is spreading as people in the developing world adopt more Western lifestyles.
- Diabetics have inadequate blood sugar control, which can lead to serious complications like heart disease and stroke, damage to the kidneys or nerves, and to blindness.
One in 10 adults will have diabetes by 2030, posing a huge challenge to healthcare systems around the world, according to a report on Monday.
The number of people living with the disease is expected to soar to 552 million by 2030 - equating to three new cases every 10 seconds - up from 366 million in 2011, unless urgent action is taken, the International Diabetes Federation said.
The vast majority of diabetics have Type 2 disease - the kind linked to poor diet, obesity and lack of exercise - and the problem is spreading as people in the developing world adopt more Western lifestyles.
Diabetics have inadequate blood sugar control, which can lead to serious complications like heart disease and stroke, damage to the kidneys or nerves, and to blindness. Worldwide deaths from the disease are now running at 4.6 million a year.
"In every country and in every community worldwide, we are losing the battle against this cruel and deadly disease," said Jean Claude Mbanya, president of the federation, which represents over 200 national associations.
Many older classes of diabetes drugs are now available as cheap generics, but global drugmakers - including Sanofi, Eli Lilly and Novo Nordisk - aim to introduce new classes of drugs that could further extend treatment options.
Global sales of diabetes medicines totaled $35 billion last year and could rise to as much as $48 billion by 2015, according to research firm IMS Health, driven by increased prevalence and treatment, especially in countries such as China, India, Mexico and Brazil.
###
(Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsA boost in microRNA may protect against obesity and diabetes
Obesity, which is associated with low-grade inflammation, is an important contributor in the development of diabetes and cardiovascular disease. While the role of several organs including adipose tissue have been…
17 March 2016
NewsPlant hormone may play a vital role in blood sugar control and diabetes management
A treatment for managing blood sugar levels might be as close as the local health food store, suggests a new research report published in the December 2015 issue of The FASEB Journal. Specifically scientists from Italy…
2 December 2015
NewsGenetic variant shown to influence women's body shape and diabetes risk
A genetic variant near the KLF14 gene regulates hundreds of genes that govern how and where women's bodies store fat, which affects their risk of developing Type 2 diabetes, according to research presented at the…





